Nice Technical DD JR. I believe the volume next week will really help us understand the tale here. As, nervous retail shorts could have created a melt up only to be leaned on by the generals. PS: great color on tomorrow makes liars of us. have a great wkend. Blessings .
Any thoughts on tape today. felt like some short covering. yet, with 3.3mm short and perhaps a blend of buying its fraction of whats left. the daily chart is improving as seen in the macs , rsi and stoch. yet, momentum is still very low. the weekly signals another leg down as the macd is showing negative divergence. not seeing any news events until late Q4 thus the theory that todays action was melt up on short shores to catch new buyers on next leg down.
aplogize for mis communication , they have proof of concept now need proof of adoption. no need to be hostile . just sharing humble opinions. praise jesus
they will need proof of adoption not just concept. buy out possible but the can needs to be kicked way down the road for both side of a deal. yet, very viable exit strategy for trov shareholders.
not worried at all. happy to buy more in the 4s or low 5s happy if it pops. as ,I stated this is just a learning for me. plenty of dry powder. just not willing to chase anything in this market. wait for things to come to you. blessings. have a great day.
watching the tape. waiting for the whack. yet,early volume is high. new buyers or short covering fake melt up to walk it down ... interesting case study here.
my point was simply they need the reimbursement contracts in place prior to mass rollout. which could take a lot more time then anticipated as it layered with bureaucracies. I've been there as a CEO of a health care start up. it was brutal.
regarding institutions DD you would think so. Yet, then why not disclose more details of pre rollout enrollments and commercial roll out and some type slide show highlighting action plan and timeline. TTOO is in the same boat in some regards but they have provided deal shops and retail guys working numbers to start modeling out opportunity. i think they sprayed the CC with merited enthusiasm but camouflaged some of the unknowns.. i believe they will get there and they have the cap runway . yet, i thinking well into 2016 before they truly monetize this platform
the other big question is the time to get approved for reimbursements as this will greatly stymie the commercial roll-out. patients will be less likely to use this disruptive and potentially out performing platform if they have to pay for it. just leads me to believe we have a long way to go before this model is bringing in meaningful revenue. dont get me wrong love the story but alot of patience is going to be required perhaps more then i wanted to admit.
Upon listening to CC last night again: I tuned out enthusiasm and was surprised at the dodging of questions. Such as the number of groups or doc signed up in pre commercial roll-out as they only would state it was oversubscribed by 500% . the same type of slippery elusiveness was highlighted about the number of reps planned or how they would ramp up roll-out and any type of rev or break-even model based on testing. the CC left me with more questions then answers. it was like a roadshow that served only appetizers. i¨m just thinking out loud in my humble and often ill informed process.
the tale of the tape will be seen over the next few trading sessions. one of the hypothesis that make some sense to me was that we´re in a lull between news as much of it comes in late into Q4 thus those looking for a window of sideways trade have hit a opening. they are not presenting at ASCO they only have a booth. thus, not expecting much from there.
Per Pepsi theory that the funds buying the last offering shorted the stock ( potentially ) on privileged information and they arranged the covering of shares with a pre arranged deal with a amt.
per his theory todays action on low volume it will get whacked back down as the shorts continue to walk it down perhaps to the jan gap of 4.36.
I watch not wanting to disprove his theory as if he is right it will be one heck of a learning curve for me. As, i have not seen this strategy implemented. i rather be wrong and learn and perhaps buy some shares in the mid 4s.
mann: great post very well thought and presented. thank you . Are you in the camp then we trade down into low 4s ? seems like a lot of risk on a news driven stock to capture another buck. Yet, I guess the other side of the argument is that the shorts are in control ? thanks in advance for any reply. blessings. RG
the testing and analytic will create a foundation of enthusiasm within the top docs in each category that can be leveraged for a wider and faster land grab versus heading to market with out the data set in hand. PS: the testing costs are nominal hardly a drag on burn these guys have a 2 year run way.